These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17060265)

  • 1. Atropine drops for drooling: a randomized controlled trial.
    De Simone GG; Eisenchlas JH; Junin M; Pereyra F; Brizuela R
    Palliat Med; 2006 Oct; 20(7):665-71. PubMed ID: 17060265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
    Mubaslat O; Lambert T
    Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sublingual use of atropine for clozapine-induced sialorrhoea: literature review and two case reports].
    van der Poorten T; De Hert M
    Tijdschr Psychiatr; 2019; 61(6):403-410. PubMed ID: 31243750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.
    Dias BLS; Fernandes AR; Maia HS
    Arq Neuropsiquiatr; 2017 May; 75(5):282-287. PubMed ID: 28591387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual administration of atropine eyedrops in children with excessive drooling - a pilot study.
    Norderyd J; Graf J; Marcusson A; Nilsson K; Sjöstrand E; Steinwall G; Ärleskog E; Bågesund M
    Int J Paediatr Dent; 2017 Jan; 27(1):22-29. PubMed ID: 26708211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of atropine in managing sialorrhea: A systematic review and meta-analysis.
    Yellepeddi VK; Race JA; McFarland MM; Constance JE; Fanaeian E; Murphy NA
    Int J Clin Pharmacol Ther; 2024 Jun; 62(6):267-277. PubMed ID: 38577753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.
    Hyson HC; Johnson AM; Jog MS
    Mov Disord; 2002 Nov; 17(6):1318-20. PubMed ID: 12465075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual atropine drops for the treatment of pediatric sialorrhea.
    Rapoport A
    J Pain Symptom Manage; 2010 Nov; 40(5):783-8. PubMed ID: 20541902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial.
    Fayoux P; Dinomais M; Shaw H; Probert N; Villain F; Pouchain D; Texier N; Auvin S
    BMJ Paediatr Open; 2023 May; 7(1):. PubMed ID: 37156563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycopyrrolate for chronic drooling in children.
    Eiland LS
    Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.
    Narayanaswami P; Geisbush T; Tarulli A; Raynor E; Gautam S; Tarsy D; Gronseth G
    Parkinsonism Relat Disord; 2016 Sep; 30():73-7. PubMed ID: 27406786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double-blind trial of sublingual atropine vs. placebo for the management of death rattle.
    Heisler M; Hamilton G; Abbott A; Chengalaram A; Koceja T; Gerkin R
    J Pain Symptom Manage; 2013 Jan; 45(1):14-22. PubMed ID: 22795904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atropine-induced toxicity after off-label sublingual administration of eyedrop for sialorrhoea treatment in neurological disabled patients.
    Michelon H; Larabi IA; Lemoine J; Alvarez JC; Genevée A; Lillo-Lelouet A; Azouvi P; Lefèvre-Dognin C; Paquereau J
    Br J Clin Pharmacol; 2021 Aug; 87(8):3364-3369. PubMed ID: 33521988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial.
    Isaacson SH; Ondo W; Jackson CE; Trosch RM; Molho E; Pagan F; Lew M; Dashtipour K; Clinch T; Espay AJ;
    JAMA Neurol; 2020 Apr; 77(4):461-469. PubMed ID: 31930364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual Atropine Sulfate Use for Sialorrhea in Pediatric Patients.
    Azapağası E; Kendirli T; Perk O; Kutluk G; Öz Tunçer G; Teber S; Çobanoğlu N
    J Pediatr Intensive Care; 2020 Sep; 9(3):196-200. PubMed ID: 32685247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    J Neurol; 2009 Apr; 256(4):563-7. PubMed ID: 19401804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of drooling in disabled patients with scopolamine patches.
    Mato A; Limeres J; Tomás I; Muñoz M; Abuín C; Feijoo JF; Diz P
    Br J Clin Pharmacol; 2010 Jun; 69(6):684-8. PubMed ID: 20565460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
    Ondo WG; Hunter C; Moore W
    Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease.
    Thomsen TR; Galpern WR; Asante A; Arenovich T; Fox SH
    Mov Disord; 2007 Nov; 22(15):2268-73. PubMed ID: 17876852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual hyoscyamine sulfate in combination with ketorolac tromethamine for ureteral colic: a randomized, double-blind, controlled trial.
    Jones JB; Giles BK; Brizendine EJ; Cordell WH
    Ann Emerg Med; 2001 Feb; 37(2):141-6. PubMed ID: 11174230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.